Related Experiment Video
Updated: Aug 14, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages
Yuliang Wang1, Yiyin Long1, Feng Wang2
1Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Abstract:
The SARS-CoV-2 Omicron is currently the predominant circulating variant in the COVID-19 pandemic. The dominating Omicron sublineages respond to host immune pressure and develop advantageous mutations or genetic recombination, which result in variants that are more contagious or better at escaping immune responses in response to previous infection or vaccination. Meanwhile, multiple genetic recombination events have been reported in coinfection cases, the majority of which have resulted from the recombination between co-circulating Omicron BA.1 (or BA.1.1) and Delta variant or BA.2. Here, we review the knowledge and characterization of recombination for SARS-CoV-2 at the population level, provide an update on the occurrence of newly circulating Omicron sublineages, and discuss the effectiveness of novel vaccines/therapeutic drugs against the Omicron variant.
More Related Videos
Related Concept Videos
Viral Recombination
Viral Mutations
Single Nucleotide Polymorphisms-SNPs
Viruses with RNA Genomes
Subviral Agents
Size and Structure of Viral Genomes

